An integrated treatment of western drugs and traditional Chinese medicine (TCM) has helped most of the over 50,000 coronavirus patients in China to recover from the deadly disease, a Chinese expert medical team said on Monday.
Compared with those only treated with TCM or western medicine, the expert team confirmed that the integrated treatment of both the medicines can more quickly control COVID-19 symptoms such as fever, cough and fatigue.
The treatment effectively reduced the chances of mild and regular symptoms developing into severe or critical ones, so as to improve the recovery rate and reduce the mortality rate in coronavirus, state-run Xinhua news agency reported.
The death toll in China due to the deadly virus rose to 3,119, while the confirmed cases climbed to 80,735, the country's National Health Commission (NHC) said.
A total of 58,600 patients have been discharged from hospitals after recovery, the NHC said.
Since coronavirus first came to light, doctors in China and the world scrambled to find a vaccine to cure the disease, the report said.
On March 6, Xinhua quoted Chinese medics saying that they found good success rate in treating coronavirus patients with some of the drugs on trials.
Chinese doctors said Tocilizumab, with the common brand name Actemra, has been included in China's latest version of diagnosis and treatment guidelines on COVID-19.
Zhou Qi, deputy secretary-general and an academician of the Chinese Academy of Sciences told media here on Friday that the drug Tocilizumab has been found effective to block the inducement of the inflammatory storm.
Yu Yanhong, deputy head of the National Administration of Traditional Chinese Medicine, told a press conference here on Monday that the combination of TCM and western medicine in COVID-19 treatment has been proved effective by the huge number of recovered patients.
According to the official data, TCM has been used in the treatment of 74,603 confirmed COVID-19 cases nationwide, accounting for 92.5 percent of the total, Xinhua report said.
TCM treatment focuses on improving the body's natural defences against an epidemic and its own ability to repair itself while maintaining the overall balance, Yu said.
TCM clinical treatment is personalised and targeted based on the differences in geography, climate and a patient's physical condition, said Zeng Yixin, deputy director of the National Health Commission.
A circular issued by the commission also encouraged the promotion of effective TCM treatment plans at the community-level epidemic prevention and control.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
